Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: Q4QAS6
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 3 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006396 | RNA processing | 6 | 3 |
GO:0006399 | tRNA metabolic process | 7 | 3 |
GO:0006400 | tRNA modification | 6 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008033 | tRNA processing | 8 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009451 | RNA modification | 5 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0030488 | tRNA methylation | 5 | 3 |
GO:0032259 | methylation | 2 | 3 |
GO:0034470 | ncRNA processing | 7 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0034660 | ncRNA metabolic process | 6 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0043412 | macromolecule modification | 4 | 3 |
GO:0043414 | macromolecule methylation | 3 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0005488 | binding | 1 | 13 |
GO:0008168 | methyltransferase activity | 4 | 13 |
GO:0008171 | O-methyltransferase activity | 5 | 13 |
GO:0008173 | RNA methyltransferase activity | 4 | 13 |
GO:0008175 | tRNA methyltransferase activity | 5 | 13 |
GO:0016740 | transferase activity | 2 | 13 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 13 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 5 | 13 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 6 | 13 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 13 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 13 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.483 |
CLV_C14_Caspase3-7 | 55 | 59 | PF00656 | 0.482 |
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.415 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 263 | 265 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 332 | 334 | PF00675 | 0.321 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.401 |
CLV_PCSK_FUR_1 | 261 | 265 | PF00082 | 0.603 |
CLV_PCSK_FUR_1 | 5 | 9 | PF00082 | 0.484 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.599 |
CLV_PCSK_KEX2_1 | 332 | 334 | PF00082 | 0.322 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.425 |
CLV_PCSK_PC1ET2_1 | 7 | 9 | PF00082 | 0.395 |
CLV_PCSK_PC7_1 | 328 | 334 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 193 | 197 | PF00082 | 0.550 |
CLV_PCSK_SKI1_1 | 328 | 332 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 359 | 363 | PF00082 | 0.371 |
CLV_Separin_Metazoa | 253 | 257 | PF03568 | 0.505 |
CLV_Separin_Metazoa | 374 | 378 | PF03568 | 0.604 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.489 |
DOC_ANK_TNKS_1 | 39 | 46 | PF00023 | 0.455 |
DOC_CYCLIN_RxL_1 | 129 | 138 | PF00134 | 0.415 |
DOC_PP1_RVXF_1 | 343 | 350 | PF00149 | 0.604 |
DOC_PP1_RVXF_1 | 478 | 484 | PF00149 | 0.464 |
DOC_PP2B_LxvP_1 | 179 | 182 | PF13499 | 0.519 |
DOC_PP2B_PxIxI_1 | 385 | 391 | PF00149 | 0.571 |
DOC_PP4_FxxP_1 | 141 | 144 | PF00568 | 0.424 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.387 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.477 |
DOC_USP7_MATH_1 | 234 | 238 | PF00917 | 0.551 |
DOC_USP7_MATH_1 | 309 | 313 | PF00917 | 0.541 |
DOC_USP7_MATH_1 | 474 | 478 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.671 |
DOC_WW_Pin1_4 | 125 | 130 | PF00397 | 0.489 |
DOC_WW_Pin1_4 | 142 | 147 | PF00397 | 0.480 |
DOC_WW_Pin1_4 | 499 | 504 | PF00397 | 0.506 |
LIG_14-3-3_CanoR_1 | 113 | 123 | PF00244 | 0.564 |
LIG_14-3-3_CanoR_1 | 132 | 141 | PF00244 | 0.397 |
LIG_14-3-3_CanoR_1 | 158 | 164 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 207 | 211 | PF00244 | 0.553 |
LIG_14-3-3_CanoR_1 | 332 | 338 | PF00244 | 0.543 |
LIG_14-3-3_CanoR_1 | 348 | 354 | PF00244 | 0.565 |
LIG_14-3-3_CanoR_1 | 427 | 435 | PF00244 | 0.581 |
LIG_14-3-3_CanoR_1 | 447 | 452 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 459 | 465 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 9 | 15 | PF00244 | 0.548 |
LIG_Actin_WH2_2 | 242 | 258 | PF00022 | 0.518 |
LIG_AP2alpha_2 | 305 | 307 | PF02296 | 0.506 |
LIG_APCC_ABBA_1 | 341 | 346 | PF00400 | 0.583 |
LIG_BIR_III_2 | 351 | 355 | PF00653 | 0.604 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.424 |
LIG_CtBP_PxDLS_1 | 441 | 447 | PF00389 | 0.416 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.520 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.526 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.531 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.447 |
LIG_FHA_1 | 338 | 344 | PF00498 | 0.583 |
LIG_FHA_1 | 358 | 364 | PF00498 | 0.395 |
LIG_FHA_2 | 401 | 407 | PF00498 | 0.479 |
LIG_FHA_2 | 53 | 59 | PF00498 | 0.567 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.562 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.567 |
LIG_Integrin_RGD_1 | 42 | 44 | PF01839 | 0.482 |
LIG_KLC1_Yacidic_2 | 402 | 406 | PF13176 | 0.479 |
LIG_LIR_Apic_2 | 138 | 144 | PF02991 | 0.445 |
LIG_LIR_Apic_2 | 402 | 407 | PF02991 | 0.478 |
LIG_LIR_Gen_1 | 227 | 234 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 421 | 428 | PF02991 | 0.612 |
LIG_LIR_Gen_1 | 434 | 444 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 421 | 425 | PF02991 | 0.612 |
LIG_LIR_Nem_3 | 434 | 439 | PF02991 | 0.395 |
LIG_PCNA_TLS_4 | 398 | 405 | PF02747 | 0.479 |
LIG_Pex14_1 | 16 | 20 | PF04695 | 0.395 |
LIG_RPA_C_Fungi | 167 | 179 | PF08784 | 0.367 |
LIG_SH2_CRK | 11 | 15 | PF00017 | 0.495 |
LIG_SH2_CRK | 436 | 440 | PF00017 | 0.262 |
LIG_SH2_PTP2 | 404 | 407 | PF00017 | 0.291 |
LIG_SH2_SRC | 404 | 407 | PF00017 | 0.416 |
LIG_SH2_STAP1 | 161 | 165 | PF00017 | 0.419 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 404 | 407 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 489 | 492 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 496 | 499 | PF00017 | 0.348 |
LIG_SH3_2 | 354 | 359 | PF14604 | 0.495 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.626 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.386 |
LIG_SH3_3 | 300 | 306 | PF00018 | 0.367 |
LIG_SH3_3 | 351 | 357 | PF00018 | 0.495 |
LIG_SH3_3 | 387 | 393 | PF00018 | 0.367 |
LIG_SH3_3 | 459 | 465 | PF00018 | 0.320 |
LIG_SUMO_SIM_par_1 | 224 | 231 | PF11976 | 0.459 |
LIG_WRC_WIRS_1 | 229 | 234 | PF05994 | 0.531 |
LIG_WRC_WIRS_1 | 78 | 83 | PF05994 | 0.549 |
MOD_CDK_SPK_2 | 499 | 504 | PF00069 | 0.359 |
MOD_CDK_SPxxK_3 | 125 | 132 | PF00069 | 0.436 |
MOD_CDK_SPxxK_3 | 499 | 506 | PF00069 | 0.393 |
MOD_CK1_1 | 400 | 406 | PF00069 | 0.311 |
MOD_CK1_1 | 418 | 424 | PF00069 | 0.183 |
MOD_CK1_1 | 454 | 460 | PF00069 | 0.346 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.609 |
MOD_CK2_1 | 460 | 466 | PF00069 | 0.426 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.485 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.544 |
MOD_GlcNHglycan | 369 | 372 | PF01048 | 0.495 |
MOD_GlcNHglycan | 410 | 413 | PF01048 | 0.397 |
MOD_GlcNHglycan | 417 | 420 | PF01048 | 0.387 |
MOD_GlcNHglycan | 443 | 447 | PF01048 | 0.361 |
MOD_GlcNHglycan | 449 | 452 | PF01048 | 0.376 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.661 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.566 |
MOD_GSK3_1 | 333 | 340 | PF00069 | 0.438 |
MOD_GSK3_1 | 447 | 454 | PF00069 | 0.359 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.479 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.601 |
MOD_N-GLC_1 | 431 | 436 | PF02516 | 0.387 |
MOD_N-GLC_2 | 50 | 52 | PF02516 | 0.568 |
MOD_N-GLC_2 | 505 | 507 | PF02516 | 0.466 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.531 |
MOD_NEK2_1 | 337 | 342 | PF00069 | 0.495 |
MOD_NEK2_1 | 367 | 372 | PF00069 | 0.367 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.488 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.463 |
MOD_NEK2_2 | 153 | 158 | PF00069 | 0.387 |
MOD_NEK2_2 | 431 | 436 | PF00069 | 0.444 |
MOD_PIKK_1 | 114 | 120 | PF00454 | 0.424 |
MOD_PIKK_1 | 474 | 480 | PF00454 | 0.320 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.493 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.627 |
MOD_PKA_2 | 255 | 261 | PF00069 | 0.564 |
MOD_PKA_2 | 320 | 326 | PF00069 | 0.493 |
MOD_PKA_2 | 347 | 353 | PF00069 | 0.433 |
MOD_PKA_2 | 426 | 432 | PF00069 | 0.400 |
MOD_PKB_1 | 170 | 178 | PF00069 | 0.387 |
MOD_PKB_1 | 326 | 334 | PF00069 | 0.449 |
MOD_Plk_1 | 205 | 211 | PF00069 | 0.499 |
MOD_Plk_1 | 234 | 240 | PF00069 | 0.490 |
MOD_Plk_1 | 431 | 437 | PF00069 | 0.457 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.481 |
MOD_Plk_4 | 228 | 234 | PF00069 | 0.414 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.367 |
MOD_Plk_4 | 400 | 406 | PF00069 | 0.320 |
MOD_Plk_4 | 431 | 437 | PF00069 | 0.262 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.591 |
MOD_ProDKin_1 | 125 | 131 | PF00069 | 0.481 |
MOD_ProDKin_1 | 142 | 148 | PF00069 | 0.475 |
MOD_ProDKin_1 | 499 | 505 | PF00069 | 0.359 |
TRG_DiLeu_BaEn_1 | 63 | 68 | PF01217 | 0.490 |
TRG_DiLeu_BaLyEn_6 | 143 | 148 | PF01217 | 0.395 |
TRG_DiLeu_BaLyEn_6 | 221 | 226 | PF01217 | 0.351 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.375 |
TRG_ENDOCYTIC_2 | 436 | 439 | PF00928 | 0.262 |
TRG_ER_diArg_1 | 170 | 173 | PF00400 | 0.628 |
TRG_ER_diArg_1 | 261 | 264 | PF00400 | 0.571 |
TRG_ER_diArg_1 | 326 | 329 | PF00400 | 0.370 |
TRG_ER_diArg_1 | 332 | 335 | PF00400 | 0.367 |
TRG_NLS_MonoExtN_4 | 5 | 11 | PF00514 | 0.386 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.483 |
TRG_Pf-PMV_PEXEL_1 | 377 | 382 | PF00026 | 0.449 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NJE0 | Trypanosomatidae | 33% | 100% |
A0A3Q8IG18 | Leishmania donovani | 52% | 100% |
A0A3S7WY71 | Leishmania donovani | 93% | 100% |
A4I0P4 | Leishmania infantum | 52% | 100% |
A4I0P5 | Leishmania infantum | 93% | 100% |
D0A723 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AIR1 | Leishmania braziliensis | 78% | 100% |
E9AWP4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 52% | 100% |
E9AWP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QAS7 | Leishmania major | 52% | 100% |
V5BR90 | Trypanosoma cruzi | 34% | 97% |